Publications by authors named "Brandon Smaglo"

Claim this Profile
A
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.
Benjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo, Catherine S Robertson, Mengfen Wu

Nat Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer.
Samuel H Cass, Ching-Wei D Tzeng, Laura R Prakash, Jessica Maxwell, Rebecca A Snyder, Brandon G Smaglo

Ann Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vagal blockade of the brain-liver axis deters cancer-associated cachexia.
Aliesha Garrett, Naama Darzi, Ashlesha Deshmukh, Nataly Rosenfeld, Omer Goldman, Brandon Smaglo

Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered exosomes with Kras specific siRNA in pancreatic cancer: a phase I study with immunological correlates.
Valerie S Kalluri, Brandon G Smaglo, Krishnan K Mahadevan, Michelle L Kirtley, Kathleen M McAndrews

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma.
Mahmoud Yousef, Abdelrahman Yousef, Mark W Hurd, Ashwathy Pillai, Saikat Chowdhury, Brandon G Smaglo

J Hematol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KRAS -Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients.
Valerie S LeBleu, Brandon G Smaglo, Krishnan K Mahadevan, Michelle L Kirtley, Kathleen M McAndrews

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma.
Mahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, Ethan B Ludmir, Ashwathy B Pillai, Brandon G Smaglo

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial.
Ethan B Ludmir, Alexander D Sherry, Bryan M Fellman, Suyu Liu, Tharakeswara Bathala, Brandon G Smaglo

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series.
Ashwathy Balachandran Pillai, Mahmoud Yousef, Abdelrahman Yousef, Kristin D Alfaro-Munoz, Brandon G Smaglo

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study.
Benjamin L Musher, Eric K Rowinsky, Brandon G Smaglo, Wasif Abidi, Mohamed Othman

Lancet Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.
Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Brandon G Smaglo

NPJ Precis Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of Established Prognostic Scoring Systems for Patients with Advanced Pancreatic Adenocarcinoma Enrolled in Immunotherapy-Based Early-Phase Clinical Trials.
Rishi Surana, Graciela Nogueras Gonzalez, Jane Rogers, David S Hong, Timothy A Yap, Brandon G Smaglo

J Gastrointest Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
Ryan W Huey, Aakash Tushar Shah, Honey V Reddi, Priyadarsini Dasari, James T Topham, Brandon G Smaglo

J Natl Cancer Inst· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.
Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Brandon G Smaglo

Res Sq· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors.
Kaysia Ludford, Won Jin Ho, Jane V Thomas, Kanwal P S Raghav, Mariela Blum Murphy, Brandon G Smaglo

J Clin Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role for Neoadjuvant Systemic Therapy for Potentially Resectable Pancreatic Cancer.
Brandon G Smaglo

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
Timothy E Newhook, Timothy J Vreeland, James F Griffin, Rebecca S S Tidwell, Laura R Prakash, Brandon G Smaglo

Ann Surg· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perineural Invasion by an Intraductal Papillary Mucinous Neoplasm of Pancreas: A Case Report of an Unusual and Unreported High-Risk Feature of Malignant Progression.
Juhi D Mahadik, Maria Luisa Machado Heredia, Brandon G Smaglo, William E Fisher, Sadhna Dhingra

Ann Clin Lab Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer.
Caitlin A Hester, Giampaolo Perri, Laura R Prakash, Jessica E Maxwell, Naruhiko Ikoma, Brandon Smaglo

J Natl Compr Canc Netw· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial.
Kanwal P Raghav, Bettzy Stephen, Daniel D Karp, Sarina A Piha-Paul, David S Hong, Brandon Smaglo

J Immunother Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary.
Kanwal Raghav, Hyunsoo Hwang, Alexandre A Jácome, Eric Bhang, Anneleis Willett, Brandon Smaglo

Clin Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait.
Ryan W Huey, Brandon G Smaglo, Jeannelyn S Estrella, Aurelio Matamoros, Michael J Overman

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I/II Study of Veliparib (ABT-888) in Combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer.
Michael J Pishvaian, Hongkun Wang, Aiwu Ruth He, Jimmy J Hwang, Brandon G Smaglo

Clin Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of HER1, HER2 dual kinase inhibitor lapatinib plus the proteasome inhibitor bortezomib in patients with advanced malignancies.
Filipa Lynce, Hongkun Wang, Emanuel F Petricoin, Paula R Pohlmann, Brandon Smaglo

Cancer Chemother Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Nodal Response After Preoperative Treatment of Gastric Adenocarcinoma.
Yvonne H Sada, Brandon G Smaglo, Joy C Tan, Hop S Tran Cao, Benjamin L Musher

J Natl Compr Canc Netw· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis